Skip to main content

Gait, Hemiplegic

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
AGRF Biofeedback GameN/A1 trial
Active Trials
NCT04013971Completed19Est. Mar 2023
AlterG
AlterGCA - Fremont
1 program
Alter G Bionic LegN/A1 trial
Active Trials
NCT03104127Completed40Est. Jul 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesAGRF Biofeedback Game
AlterGAlter G Bionic Leg

Clinical Trials (2)

Total enrollment: 59 patients across 2 trials

NCT04013971Human BioSciencesAGRF Biofeedback Game

Innovative Biofeedback Interface for Enhancing Stroke Gait Rehabilitation

Start: Apr 2022Est. completion: Mar 202319 patients
N/ACompleted
NCT03104127AlterGAlter G Bionic Leg

Effect of Using a Lower Limb Robotic Device for Patients With Chronic Stroke

Start: Apr 2017Est. completion: Jul 201940 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.